Cristian Coarfa Selected Research

Biomarkers (Surrogate Marker)

8/2023	Multiomic Investigations into Lung Health and Disease.
12/2022	Metabolome and microbiome multi-omics integration from a murine lung inflammation model of bronchopulmonary dysplasia.
1/2022	Plasma protein biomarkers for primary graft dysfunction after lung transplantation: a single-center cohort analysis.
6/2021	Perspectives for systems biology in the management of tuberculosis.
1/2021	Reverse Phase Protein Array Reveals Correlation of Retinoic Acid Metabolism With Cardiomyopathy in Friedreich's Ataxia.
1/2021	Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer.
12/2019	Metabolomic biomarkers are associated with mortality in patients with cirrhosis caused by primary biliary cholangitis or primary sclerosing cholangitis.
12/2018	The Emerging Roles of Steroid Hormone Receptors in Ductal Carcinoma in Situ (DCIS) of the Breast.
12/2018	Distinct Lipidomic Landscapes Associated with Clinical Stages of Urothelial Cancer of the Bladder.
7/2018	Unbiased Lipidomic Profiling of Triple-Negative Breast Cancer Tissues Reveals the Association of Sphingomyelin Levels with Patient Disease-Free Survival.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cristian Coarfa Research Topics

Disease

93	Neoplasms (Cancer) 12/2023 - 06/2011
26	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 04/2013
18	Breast Neoplasms (Breast Cancer) 10/2023 - 04/2013
11	Inflammation (Inflammations) 01/2023 - 03/2014
10	Carcinogenesis 01/2024 - 06/2011
10	Neoplasm Metastasis (Metastasis) 11/2021 - 04/2013
8	Hyperoxia 01/2023 - 01/2016
6	Osteosarcoma (Osteogenic Sarcoma) 01/2024 - 09/2016
6	Disease Progression 12/2023 - 01/2020
6	Urinary Bladder Neoplasms (Bladder Cancer) 11/2019 - 10/2017
5	Triple Negative Breast Neoplasms 01/2024 - 03/2016
5	Infections 12/2023 - 01/2018
5	Lung Injury 01/2023 - 01/2017
5	Insulin Resistance 12/2022 - 12/2018
5	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 07/2022 - 01/2017
5	Neuroblastoma 01/2022 - 06/2011
5	Cardiomyopathies (Cardiomyopathy) 01/2021 - 01/2020
4	Obesity 04/2024 - 12/2018
4	Squamous Cell Carcinoma of Head and Neck 01/2023 - 01/2018
4	Tuberculosis (Tuberculoses) 01/2022 - 01/2020
4	Hypoxia (Hypoxemia) 01/2022 - 07/2017
4	Adenocarcinoma 01/2021 - 10/2014
4	Laminopathies 01/2020 - 01/2018
4	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2020 - 12/2018
3	Fibrosis (Cirrhosis) 05/2023 - 01/2018
3	Bronchopulmonary Dysplasia 01/2023 - 01/2021
3	Bites and Stings (Sting) 01/2021 - 01/2020
3	Male Infertility (Male Sterility) 12/2020 - 01/2019
3	Ovarian Neoplasms (Ovarian Cancer) 12/2019 - 05/2016
2	Genomic Instability 02/2024 - 01/2014
2	Type 2 Diabetes Mellitus (MODY) 01/2024 - 01/2015
2	Hepatocellular Carcinoma (Hepatoma) 10/2023 - 08/2015
2	Leiomyoma (Uterine Fibroids) 09/2023 - 06/2023
2	Lung Diseases (Lung Disease) 08/2023 - 09/2010
2	Opioid-Related Disorders (Opiate Addiction) 01/2023 - 01/2022
2	Rheumatoid Arthritis 12/2022 - 01/2019
2	Hyperplasia 12/2022 - 10/2020
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 01/2020
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

35	Proteins (Proteins, Gene)FDA Link 02/2024 - 04/2013
19	MicroRNAs (MicroRNA)IBA 10/2023 - 09/2010
17	Androgen Receptors (Androgen Receptor)IBA 01/2023 - 04/2013
13	Transcription Factors (Transcription Factor)IBA 01/2024 - 04/2013
13	Biomarkers (Surrogate Marker)IBA 08/2023 - 10/2015
13	RNA (Ribonucleic Acid)IBA 01/2023 - 03/2014
12	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 05/2013
12	AndrogensIBA 01/2022 - 04/2013
11	EnzymesIBA 01/2024 - 01/2017
9	Protein Isoforms (Isoforms)IBA 01/2024 - 01/2015
9	DNA (Deoxyribonucleic Acid)IBA 07/2022 - 01/2014
8	ChromatinIBA 02/2024 - 01/2020
8	CytokinesIBA 10/2022 - 09/2010
8	Messenger RNA (mRNA)IBA 01/2022 - 01/2015
7	LipidsIBA 12/2023 - 03/2014
7	InterferonsIBA 11/2021 - 12/2018
7	Hormones (Hormone)IBA 01/2021 - 01/2016
6	Lamin Type A (Lamin A)IBA 07/2022 - 01/2018
5	Fatty Acids (Saturated Fatty Acids)IBA 01/2024 - 03/2016
5	CarcinogensIBA 10/2023 - 08/2015
5	Oxygen (Dioxygen)IBA 01/2023 - 12/2017
5	Long Noncoding RNAIBA 12/2022 - 11/2015
5	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2020 - 04/2013
5	Estrogen ReceptorsIBA 01/2020 - 07/2014
4	Lysine (L-Lysine)FDA Link 04/2024 - 08/2016
4	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 01/2019
4	XenobioticsIBA 01/2023 - 08/2016
4	LigandsIBA 01/2023 - 11/2019
4	Insulin (Novolin)FDA Link 12/2022 - 01/2017
4	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2019
4	CateninsIBA 01/2021 - 01/2019
4	Phenobarbital (Luminal)FDA Link 12/2018 - 01/2015
3	Glutamine (L-Glutamine)FDA Link 04/2024 - 03/2015
3	Carnitine (L-Carnitine)FDA LinkGeneric 01/2024 - 03/2016
3	Estrogen Receptor alphaIBA 10/2023 - 07/2014
3	Endocrine DisruptorsIBA 09/2023 - 08/2016
3	SmokeIBA 01/2022 - 10/2017
3	Histones (Histone)IBA 01/2022 - 07/2014
3	Estrogens (Estrogen)FDA Link 01/2021 - 11/2015
3	Tamoxifen FDA LinkGeneric 01/2021 - 07/2014
3	Male Contraceptive Agents (Male Contraceptives)IBA 12/2020 - 01/2019
3	Phosphotransferases (Kinase)IBA 01/2017 - 03/2015
2	Glutamic Acid (Glutamate)FDA Link 04/2024 - 01/2023
2	Amino Acids FDA Link 01/2024 - 01/2023
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2023 - 01/2017
2	B7-H1 AntigenIBA 01/2023 - 01/2022
2	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 01/2023 - 01/2017
2	Opioid Analgesics (Opioids)IBA 01/2023 - 01/2022
2	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 01/2023 - 01/2017
2	Keratins (Keratin)IBA 01/2022 - 11/2019
2	Peptides (Polypeptides)IBA 01/2022 - 01/2019
2	AntibodiesIBA 01/2021 - 01/2021
2	Estradiol (Delestrogen)FDA LinkGeneric 01/2021 - 11/2015
2	Aromatase InhibitorsIBA 01/2021 - 01/2021
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 01/2016

Therapy/Procedure

37	Therapeutics 10/2023 - 04/2013
8	Castration 12/2023 - 12/2014
6	Drug Therapy (Chemotherapy) 01/2022 - 07/2013
4	Immunotherapy 01/2022 - 01/2019
2	Radiotherapy 07/2021 - 01/2018